Tag: Contrast agent

Over 450 million gadolinium-based contrast agent (GBCA) doses have been administered worldwide since 1988, yet a small amount of gadolinium can stay in the body for months or even years. Understanding **how long does gadolinium stay in the body** is crucial for patient safety and informed consent during magnetic resonance imaging (MRI) procedures.

For patients with healthy kidney function, approximately 90% of a gadolinium-based contrast agent (GBCA) is eliminated from the body within 24 hours. This natural process answers the question of how to get rid of gadolinium after an MRI for most people, but some trace amounts can be retained long-term.

According to the European Medicines Agency, SonoVue is contraindicated in patients with severe pulmonary hypertension, right-to-left shunts, and uncontrolled systemic hypertension. Knowing what are the contraindications for SonoVue is crucial for ensuring patient safety before receiving this ultrasound contrast agent, as its use is restricted in certain serious medical conditions.

Over 40% of all Magnetic Resonance Imaging (MRI) procedures utilize gadolinium-based contrast agents (GBCAs) to enhance imaging clarity. These agents are designed for rapid clearance from the body, but understanding how is gadolinium eliminated from the body is crucial, especially concerning patient safety and long-term retention.

Used extensively in modern diagnostic medicine, Omnipaque (iohexol) is an iodinated contrast agent designed to enhance the visibility of internal body structures during medical imaging. In fact, it is relied upon by radiologists and physicians worldwide to improve the clarity of images from a variety of scans, leading to more accurate diagnoses.

In 2017, the FDA approved Tagitol V as the first dedicated fecal tagging agent for computed tomography (CT) colonography. What is Tagitol and how does this contrast agent aid in a virtual colonoscopy? This oral suspension, containing barium sulfate, is a vital tool for diagnostic imaging, helping physicians differentiate between retained stool and actual colon abnormalities.

First synthesized in 1901 by French pharmacist Marcel Guerbet, Lipiodol, also known as ethiodized oil, is an iodinated poppy seed oil with unique properties that have established it as a versatile tool in interventional radiology. From diagnostic imaging to targeted cancer therapy, the meaning and applications of this compound have evolved significantly throughout medical history.